Literature DB >> 16419737

Characterization of excretory/secretory endopeptidase and metallo-aminopeptidases from Taenia crassiceps metacestodes.

Salman Baig1, Raymond T Damian, Jorge Morales-Montor, Paula Olecki, Jamil Talhouk, Rayhan Hashmey, A Clinton White.   

Abstract

Cysticercosis is caused by Taenia spp. metacestodes, which must survive in the host tissues to complete their life cycle. Their survival depends on their control of host immune responses. Because many parasites use proteases to modulate host responses, we examined culture media from Taenia crassiceps metacestodes for protease activity using peptide substrates. We identified prominent aminopeptidase activity at neutral pH, which was inhibited by chelating agents and partially inhibited by the aminopeptidase inhibitor, bestatin. Endopeptidase substrates were optimally cleaved at slightly acidic pH and endopeptidase activity was inhibited by cysteine protease inhibitors. Gel filtration FPLC and subsequent visualization by silver staining revealed a metallo-aminopeptidase of molecular weight 21 kDa and cysteine proteases of Mr 70 and 64 kDA. Recombinant IL-2 was digested when incubated with parasite culture supernatants, but not with control media. IL-2 degradation was completely inhibited by 1,10 phenanthroline and partially inhibited by bestatin, suggesting that a metallo-aminopeptidase was responsible. Incubation of human IgG with culture supernatants resulted in complete degradation of IgG, which was blocked by cysteine protease inhibitors. These observations demonstrate that Taenia spp. metacestodes secrete a number of proteolytic enzymes, which may target molecules from the host immune system and assist in evasion of the host immune response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16419737     DOI: 10.1645/GE-200R1.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  5 in total

1.  The highly antigenic 53/25 kDa Taenia solium protein fraction with cathepsin-L like activity is present in the oncosphere/cysticercus and induces non-protective IgG antibodies in pigs.

Authors:  Mirko Zimic; Mónica Pajuelo; Robert H Gilman; Andrés H Gutiérrez; Luis D Rueda; Myra Flores; Nancy Chile; Manuela Verástegui; Armando Gonzalez; Héctor H García; Patricia Sheen
Journal:  Vet Immunol Immunopathol       Date:  2011-11-11       Impact factor: 2.046

Review 2.  Treatment of neurocysticercosis: current status and future research needs.

Authors:  T E Nash; G Singh; A C White; V Rajshekhar; J A Loeb; J V Proaño; O M Takayanagui; A E Gonzalez; J A Butman; C DeGiorgio; O H Del Brutto; A Delgado-Escueta; C A W Evans; R H Gilman; S M Martinez; M T Medina; E J Pretell; J Teale; H H Garcia
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

3.  Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis.

Authors:  Mirko Zimic; Mónica Pajuelo; Daniel Rueda; César López; Yanina Arana; Yesenia Castillo; Maritza Calderón; Silvia Rodriguez; Patricia Sheen; Joseph M Vinetz; Armando Gonzales; Héctor H García; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2009-06       Impact factor: 2.345

4.  Regulatory T Cells as an Escape Mechanism to the Immune Response in Taenia crassiceps Infection.

Authors:  Laura Adalid-Peralta; Alexander Lopez-Roblero; Cynthia Camacho-Vázquez; Marisol Nájera-Ocampo; Adrián Guevara-Salinas; Nataly Ruiz-Monroy; Marlene Melo-Salas; Valeria Morales-Ruiz; Dina López-Recinos; Edgar Ortiz-Hernández; Jocelyne Demengeot; Joel A Vazquez-Perez; Asiel Arce-Sillas; Sandra Gomez-Fuentes; Robert Michael Evans Parkhouse; Gladis Fragoso; Edda Sciutto; Edgar E Sevilla-Reyes
Journal:  Front Cell Infect Microbiol       Date:  2021-04-13       Impact factor: 5.293

5.  Case Report: Disseminated Cysticercosis due to Intentional Ingestion of Parasitic Worm Eggs for Weight Loss.

Authors:  Han-Yu Zhang; Guo-Xing Wang; Yue-Yan Xing; Miao-Rong Xie
Journal:  Am J Trop Med Hyg       Date:  2021-11-29       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.